A Girl with End-Stage Kidney Disease Due to Granulomatosis with Polyangiitis Presenting with Gastrointestinal Bleeding “a rare presentation”
DOI:
https://doi.org/10.61882/ijkd.20.4.9390Keywords:
Granulomatosis with polyangiitis, Small-bowel microaneurysms, Gastrointestinal bleeding, ESKD, Case reportAbstract
Granulomatosis with polyangiitis (GPA) is an uncommon vasculitis affecting small- and medium-sized vessels, predominantly in adults (average age approximately 45 years) and infrequently in children. It can involve multiple organ systems.
In patients with end-stage kidney disease (ESKD) due to GPA, disease activity is often tends to wane after the commencement of dialysis.
We report a 12-year-old girl with ESKD due to GPA who presented with severe gastrointestinal (GI) bleeding and profound anemia, owing to diffuse microaneurysms in the small bowel (particularly the ileum) and colon—an exceedingly rare manifestation. She responded dramatically to induction therapy comprising methylprednisolone pulse, plasmapheresis, rituximab followed by maintenance therapy with prednisolone and mycophenolate mofetil.
This case highlights that while the recurrence risk of ANCA-associated vasculitis in dialysis patients is low, the possibility remains and may present with atypical extrarenal involvement. Given the elevated risk of infection with immunosuppression in ESKD patients, maintenance immunosuppressive therapy may be discontinued in the absence of extrarenal disease—but this decision necessitates careful consideration.
Downloads
References
1 . Sahil Bagai, Aman Sharma, Rajesh Gupta et al.Gastrointestinal involvement in granulomatosis with polyangiitis: case report and review. Indian J.Nephrol 2019; 415–418. DOI: 10.4103/ijn.IJN_141_18
2. Frauke Weidanz, Clara J Day, Peter Hewins, et
al. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCAassociated vasculitis. Am J Kidney Dis 2007; 36–46. DOI: 10.1053/j.ajkd.2007.04.018
3. Allen A, C Pusey and G Gaskin, et al. Outcome of
renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998; 1258–1263. DOI: 10.1681/ASN.V971258
4. Sofia Lionaki, Susan L Hogan, Caroline E Jennette, et al. The clinical course of ANCA small vessel vasculitis on chronic dialysis. Kidney Int 2009; 644–651. DOI: 10.1038/ki.2009.218
5. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl 2012; 139–274. DOI:10.1038/kisup.2012.9
Downloads
Published
Data Availability Statement
Response to this question, the answer is positive. Research data can be made available to readers through bibliometrics and google Scholar